Haas Kevin Richard 4
4 · VERACYTE, INC. · Filed Apr 14, 2026
Research Summary
AI-generated summary of this filing
Veracyte (VCYT) Chief Dev & Tech Officer Kevin Haas Receives 44,221 RSUs
What Happened Kevin Richard Haas, Veracyte’s Chief Development and Technology Officer, was granted 44,221 restricted stock units (RSUs) on April 10, 2026. The Form 4 reports the acquisition price as $0.00 (aggregate reported value $0), reflecting an award of equity rather than a cash purchase or sale. This was an equity grant for compensation/retention purposes, not an open-market purchase or sale.
Key Details
- Transaction date: April 10, 2026; recorded on Form 4 filed April 14, 2026 (timely).
- Transaction type: Award/Grant (RSUs) — 44,221 shares acquired at $0.00.
- Shares owned after transaction: Not specified in the filing.
- Footnote: RSUs vest 25% on June 2, 2027 and then 1/16 of the total per quarter thereafter, subject to continued employment (footnote F1).
- No 10b5-1 plan, tax-withholding sale, or sale reported in this filing.
Context RSU grants are common executive compensation and generally indicate future vesting-based ownership rather than an immediate cash transaction. The reported $0 reflects the award nature of the grant; any taxable/event value will depend on company stock price at vesting. This filing does not indicate any immediate sale of shares.
Insider Transaction Report
- Award
Common Stock
[F1]2026-04-10+44,221→ 44,221 total
Footnotes (1)
- [F1]Restricted stock units awarded on April 10, 2026 vest 25% on June 2, 2027 and 1/16 per quarter thereafter subject to continuing employment of the Reporting Person on each vesting date.